The FDA granted orphan designation to Vor Biopharma’s treatment of acute myeloid leukemia, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VOR:
